The biotechnology company Archivel Farma, a member of CATALONIA.HEALTH, announces the opening of a business line as the Contract Development and Manufacturing Organization (CDMO). The initiative will focus on the manufacture of clinical batches under Good Manufacturing Practices (GMP), especially oriented to biological, sterile, lyophilized products, both for human and veterinary use.
The new line of business will allow the company to offer a comprehensive service that encompasses everything from the initial stages of product development to the production of clinical batches, ensuring compliance with the highest regulatory standards.
The team of Archivel Farma expresses its enthusiasm with the launch of this new line as CDMO, which reinforces the mission of supporting biotechnology companies in the development of innovative treatments. Thanks to the experience in injectable lyophilized biological products, Archivel Farma is positioned as a strategic partner for those companies that seek to bring their products to the clinic efficiently and safely.
In 2024, the company is making significant investments, particularly in adapting to the new Annex-1 GMP regulations. Archivel Farma is equipped with sterile rooms, BSL-3 biocontainment facilities, as well as Quality Control and Research laboratories, supported by a team of highly trained experts, ensuring a quality manufacturing process.
Comments